Are nondepolarizing neuromuscular blocking agents truly a risk factor for late-onset ventilator-associated pneumonia?
Dongelmans
Dave A
DA
Schultz
Marcus J
MJ
D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects / Q000627:therapeutic use; D011014:Pneumonia / Q000209:etiology*; D012121:Respiration, Artificial / Q000009:adverse effects*; D012307:Risk Factors; D014947:Wounds and Injuries / Q000628:therapy
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D003473:Neuromuscular Nondepolarizing Agents; D000666:Amphotericin B